Astrana Health (NASDAQ:ASTH) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Astrana Health (NASDAQ:ASTHGet Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01), Briefing.com reports. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The firm had revenue of $404.36 million during the quarter, compared to analyst estimates of $413.84 million. During the same quarter in the previous year, the business earned $0.42 EPS. Astrana Health’s revenue for the quarter was up 19.9% on a year-over-year basis. Astrana Health updated its FY24 guidance to $1.28 to $1.52 EPS.

Astrana Health Trading Up 0.2 %

Shares of ASTH stock traded up $0.09 during trading hours on Friday, hitting $39.14. The company’s stock had a trading volume of 3,262 shares, compared to its average volume of 152,299. The company has a current ratio of 2.11, a quick ratio of 2.11 and a debt-to-equity ratio of 0.42. The stock has a fifty day moving average of $40.12. Astrana Health has a twelve month low of $28.86 and a twelve month high of $45.71. The firm has a market capitalization of $2.19 billion, a PE ratio of 29.58, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on ASTH shares. Stifel Nicolaus dropped their price objective on Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Wednesday. Jefferies Financial Group started coverage on Astrana Health in a research note on Monday, February 26th. They issued a “buy” rating and a $50.00 price objective for the company. Finally, Truist Financial boosted their target price on Astrana Health from $41.00 to $44.00 and gave the stock a “hold” rating in a research report on Friday, March 1st.

Read Our Latest Report on ASTH

Astrana Health Company Profile

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

See Also

Earnings History for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.